Restricted accessResearch articleFirst published online 2026-4
Choroid plexus–glymphatic axis disruption in Alzheimer's disease: Cerebrospinal fluid expansion as a mediator of metabolic dysfunction and cognitive decline
The choroid plexus (ChP) and glymphatic system are crucial for cerebrospinal fluid (CSF) homeostasis and brain waste clearance. While their individual roles in Alzheimer's disease (AD) are recognized, the mechanisms linking ChP structural changes, glymphatic dysfunction, and CSF dynamics to metabolic and cognitive decline remain unclear.
Objective
We aimed to investigate the interrelationships among ChP volume, glymphatic function, CSF volumetric changes, cerebral glucose metabolism, and cognitive status across the AD spectrum.
Methods
This cross-sectional study included 142 participants from the Alzheimer's Disease Neuroimaging Initiative (ADNI) database, categorized as cognitively normal (NC, n = 38), early mild cognitive impairment (EMCI, n = 31), late mild cognitive impairment (LMCI, n = 31), and AD (n = 42). We analyzed multimodal neuroimaging data, including normalized ChP volume (nChP), CSF sub-volumes, the diffusion tensor imaging along the perivascular space (DTI-ALPS) index, and [18F]-FDG-PET standardized uptake value ratios. Partial correlation and mediation analyses were performed, adjusting for covariates.
Results
Increased nChP correlated with larger CSF (nTotal-CSF: r = 0.324, FDR-p = 0.004), lower DTI-ALPS, and reduced FDG. nChP drove cognitive decline via two paths: “nChP→nTotal-CSF→ Mini-Mental State Examination (MMSE)” (44.1% total effect) and “nChP→DTI-ALPS→FDG→MMSE” (9.9%, p < 0.001). CSF showed spatial mediation: nCSF-LV (66.20% on metabolism) outperformed external CSF (38.90%); DTI-ALPS negatively correlated with nCSF-LV (r = −0.406, FDR-p < 0.01).
Conclusions
Our findings demonstrate that ChP enlargement is linked to cognitive impairment through pathways involving CSF dynamics and glymphatic function, with cerebral hypometabolism as a key downstream effector. This study posits a “CSF dynamics imbalance” cascade in AD, highlighting the potential of targeting Choroid Plexus-CSF-glymphatic axis for early diagnosis and intervention.
IvanovaAVKutuzovaADKuzmichevIA, et al.Alzheimer’s disease: from molecular mechanisms to promising therapeutic strategies. Int J Mol Sci2025; 26: 9444.
3.
RajmohanRReddyPH. Amyloid beta and phosphorylated tau accumulations cause abnormalities at synapses of Alzheimer’s disease neurons. J Alzheimers Dis2017; 57: 975–999.
4.
PascoalTAMathotaarachchiSMohadesS, et al.Amyloid-β and hyperphosphorylated tau synergy drives metabolic decline in preclinical Alzheimer’s disease. Mol Psychiatry2017; 22: 306–311.
5.
DamkierHHBrownPDPraetoriusJ. Cerebrospinal fluid secretion by the choroid plexus. Physiol Rev2013; 93: 1847–1892.
6.
JessenNAMunkASFLundgaardI, et al.The glymphatic system – a beginner’s guide. Neurochem Res2015; 40: 2583–2599.
7.
IliffJJWangMLiaoY, et al.A paravascular pathway facilitates CSF flow through the brain parenchyma and the clearance of interstitial solutes, including amyloid β. Sci Transl Med2012; 4: 147ra111.
8.
KrzyzanowskaACarroE. Pathological alteration in the choroid plexus of Alzheimer’s disease: implication for new therapy approaches. Front Pharmacol2012; 3: 75.
9.
DelvenneAVandendriesscheCGobomJ, et al.Involvement of the choroid plexus in Alzheimer’s disease pathophysiology: findings from mouse and human proteomic studies. Fluids Barriers CNS2024; 21: 58.
10.
JiangJZhuoZWangA, et al.Choroid plexus volume as a novel candidate neuroimaging marker of the Alzheimer’s continuum. Alzheimers Res Ther2024; 16: 149.
11.
LiuYZhangYLiX, et al.Association of choroid plexus volume with white matter microstructure, glymphatic function, and peripheral systemic inflammation in Alzheimer’s disease. Transl Psychiatry2025; 15: 289.
12.
ZhangYHuangGGengJ, et al.DTI-ALPS index-assessed glymphatic dysfunction mediates Alzheimer's cognitive decline via amyloid-β-dependent pathways: multimodal PET/MRI study. Eur J Nucl Med Mol Imaging2025; 53: 467–479.
13.
KamagataKAndicaCTakabayashiK, et al.Association of MRI indices of glymphatic system with amyloid deposition and cognition in mild cognitive impairment and Alzheimer disease. Neurology2022; 99: e2648–e2660.
14.
OttBRCohenRAGongvatanaA, et al.Brain ventricular volume and cerebrospinal fluid biomarkers of Alzheimer’s disease. J Alzheimers Dis2010; 20: 647–657.
15.
MissoriPCurràA. Progressive cognitive impairment evolving to dementia parallels parieto-occipital and temporal enlargement in idiopathic chronic hydrocephalus: a retrospective cohort study. Front Neurol2015; 6: 15.
16.
LinWChenHZhangZ, et al.Multimodal MRI reveals impaired glymphatic function with choroid plexus enlargement and cerebrospinal fluid expansion in Alzheimer’s disease. Sci Rep2025; 15: 30409.
17.
ZhaoDWangJZhuY, et al.Targeting the glymphatic system: aβ accumulation and phototherapy strategies across different stages of Alzheimer’s disease. Transl Neurodegener2025; 14: 28.
18.
ZhouLButlerTAWangXH, et al.Region-informed machine learning model for choroid plexus segmentation in Alzheimer’s disease. Front Aging Neurosci2025; 17: 1613320.
19.
FischlBSalatDHBusaE, et al.Whole brain segmentation: automated labeling of neuroanatomical structures in the human brain. Neuron2002; 33: 341–355.
20.
TadayonEMoretBSprugnoliG, et al.Improving choroid plexus segmentation in the healthy and diseased brain: relevance for tau-PET imaging in dementia. J Alzheimers Dis2020; 74: 1057–1068.
21.
KamraouiRATaVTTourdiasT, et al.Deeplesionbrain: towards a broader deep-learning generalization for multiple sclerosis lesion segmentation. Med Image Anal2022; 76: 102312.
22.
CoupéPMansencalBClémentM, et al.Assemblynet: a large ensemble of CNNs for 3D whole brain MRI segmentation. Neuroimage2020; 219: 117026.
23.
PasternakOSochenNGurY, et al.Free water elimination and mapping from diffusion MRI. Magn Reson Med2009; 62: 717–730.
24.
GaryfallidisEBrettMAmirbekianB, et al.Dipy, a library for the analysis of diffusion MRI data. Front Neuroinform2014; 8: 8.
25.
TaokaTMasutaniYKawaiH, et al.Evaluation of glymphatic system activity with the diffusion MR technique: diffusion tensor image analysis along the perivascular space (DTI-ALPS) in Alzheimer’s disease cases. Jpn J Radiol2017; 35: 172–178.
26.
TaokaTItoRNakamichiR, et al.Reproducibility of diffusion tensor image analysis along the perivascular space (DTI-ALPS) for evaluating interstitial fluid diffusivity and glymphatic function: cHanges in Alps index on multiple conditiON acquIsition eXperiment (CHAMONIX) study. Jpn J Radiol2022; 40: 147–158.
27.
TaokaTItoRNakamichiR, et al.Diffusion tensor image analysis along the perivascular space (DTI-ALPS): revisiting the meaning and significance of the method. Magn Reson Med Sci2024; 23: 268–290.
HsuJLWeiYCTohCH, et al.Magnetic resonance images implicate that glymphatic alterations mediate cognitive dysfunction in Alzheimer disease. Ann Neurol2023; 93: 164–174.
30.
JensenDBToft-BertelsenTLBarbuskaiteD, et al.The Na+, K+, 2Cl− cotransporter, not aquaporin 1, sustains cerebrospinal fluid secretion while controlling brain K+ homeostasis. Adv Sci (Weinh)2025; 12: e2409120.
31.
KantSStopaEGJohansonCE, et al.Choroid plexus genes for CSF production and brain homeostasis are altered in Alzheimer’s disease. Fluids Barriers CNS2018; 15: 34.
32.
UenoMChibaYMurakamiR, et al.Transporters, ion channels, and junctional proteins in choroid plexus epithelial cells. Biomedicines2024; 12: 708.
33.
KlistornerSBarnettMHWangC, et al.Longitudinal enlargement of choroid plexus is associated with chronic lesion expansion and neurodegeneration in RRMS patients. Mult Scler2024; 30: 496–504.
34.
MillwardJMRamos DelgadoPSmorodchenkoA, et al.Transient enlargement of brain ventricles during relapsing-remitting multiple sclerosis and experimental autoimmune encephalomyelitis. JCI Insight2020; 5: e140040.
35.
RiciglianoVAGMorenaEColombiA, et al.Choroid plexus enlargement in inflammatory multiple sclerosis: 3.0-T MRI and translocator protein PET evaluation. Radiology2021; 301: 166–177.
36.
HuangSYZhangYRGuoY, et al.Glymphatic system dysfunction predicts amyloid deposition, neurodegeneration, and clinical progression in Alzheimer’s disease. Alzheimers Dement2024; 20: 3251–3269.
37.
Tsitsou-KampeliASuzziSSchwartzM. The immune and metabolic milieu of the choroid plexus as a potential target in brain protection. Trends Neurosci2024; 47: 573–582.
38.
SimonMJIliffJJ. Regulation of cerebrospinal fluid (CSF) flow in neurodegenerative, neurovascular and neuroinflammatory disease. Biochim Biophys Acta2016; 1862: 442–451.
39.
MunicioCCarreroLAntequeraD, et al.Choroid plexus aquaporins in CSF homeostasis and the glymphatic system: their relevance for Alzheimer's disease. Int J Mol Sci2023; 24: 878.
40.
RasmussenMKMestreHNedergaardM. Fluid transport in the brain. Physiol Rev2022; 102: 1025–1151.
41.
DeffnerFGleiserCMattheusU, et al.Aquaporin-4 expression in the human choroid plexus. Cell Mol Life Sci2022; 79: 90.
42.
SilvaISilvaJFerreiraR, et al.Glymphatic system, AQP4, and their implications in Alzheimer's disease. Neurol Res Pract2021; 3: 5.
43.
JeongSHParkCJChaJ, et al.Choroid plexus volume, amyloid burden, and cognition in the Alzheimer’s disease continuum. Aging Dis2025; 16: 552–564.
44.
SalmanMMKitchenPWoodroofeMN, et al.Emerging roles for dynamic aquaporin-4 subcellular relocalization in CNS water homeostasis. Brain2022; 145: 64–75.
45.
MarnaneMAl-JawadiOOMortazaviS, et al.Periventricular hyperintensities are associated with elevated cerebral amyloid. Neurology2016; 86: 535–543.
46.
ZhouZKuoPHBozokiAC, et al.Quantifying ventricular CSF clearance in the human brain using dynamic 18F-FDG PET imaging. medRxiv 2025. DOI: https://doi.org/10.1101/2025.04.07.25325241 [Preprint]. Posted April 09, 2025.
47.
KeilSAJanssonDBraunM, et al.Glymphatic dysfunction in Alzheimer's disease: a critical appraisal. Science2025; 389: eadv8269.
48.
TaokaTIwamotoKMiyataS, et al.Contribution of white matter microstructure to diffusion tensor image analysis along perivascular space in obstructive sleep apnea. Jpn J Radiol2025; 43: 1926–1941.
49.
RingstadG. Glymphatic imaging: a critical look at the DTI-ALPS index. Neuroradiology2024; 66: 157–160.
